Innovation Always carry out independent innovation as the source power for corporate development HomeR&D Innovation Situation Learn More 03-25 2019 Fosun Pharma Releases 2018 Annual Results：Adhere to Innovation and Internationalization with Steady Growth in Pharmaceutical Manufacturing and R&D segment Revenue RMB 24.92 billion, up 34.45% YOY Cash flows from operating activities RMB 2.95 billion, up 14.34% YOY R&D Investment RMB 2.51 billion, up 63.92% YOY 02-25 2019 Fosun Pharma Has Opened a New Era for Biosimilar in China Henlius Receives NMPA Approval for Its First Product HLX01 10-29 2017 Fosun Pharma Drug for Treatment of Leukaemia Gets US FDA Approval for Clinical Trials 07-11 2017 ND Application of Henlius (Committed to the Patient Affordable Innovation) for Another Innovative McAb 07-11 2017 Boosting Transformation and Implementation of International Innovative Technologies by Incubation Fosun Pharma to Establish Technology Innovation Incubation Platform RMB 2,510 million 2018 R&D investment was +63.92% A year-on-year increase of R&D System Fosun Pharma alsways regards independent innovation as the driving force for enterprise development and continuously optimizes its pharmaceutical R&D system that integrates imitation and innovation. Details R&D Teams Fosun Pharma has National-Recognized Enterprise Technology Center, and has established efficient international R&D teams in Shanghai, Chongqing and San Francisco. Details Milestones We’ve achieved a lot of achievements in new drugs, bio-similar drugs, biosimilar drugs, vaccines and other projects The rich product pipeline will continue to lay a good foundation for the continuous improvement of the future performance of the Company. Details Strategic Alliance Fosun Pharma innovatively integrates domestic resources and constantly enhances its R&D capacity. Fosun Pharma, together with domestic famous scientific research institutes enterprises establishes“Industrial technology innovation strategic alliance”, one of the “ Industry-university-research Alliance” in National Science and Technology Major Project of the Ministry of Science and Technology of China. Details Therapeutic Areas Fosun Pharma always regards independent innovation as the driving force for enterprise development , covering the important areas in pharmaceutical industry, medical diagnosis and medical device . Details Contact Us To speed up the industrialization of science and technology, Fosun Pharma Group searches for new technologies and projects all over the world, including patent licensing, technology purchase, joint development. We focus on the fields of diabetes, liver diseases, anti-infection, cancer and cardiovascular disease, looking forward to new cooperation opportunities. We also look forward to working with you for the future of Chinese pharmaceuticals and health industry. Su Shufang Tel: 86-21-33987590 Fax: 86-21-33987020 Mail:sushf@fosunpharma.com Zhang Zhenshan Tel: 86-21-33987591 Fax:86-21-33987020 Mail: zhangzhsh@fosunpharma.com Yuan Ning Tel: 86-21-63325899 Fax:86-21-33987020 Mail: yuann@fosunpharma.com Liu Xiaohua Tel: 86-21-33987251 Fax:86-21-33987020 Mail: liuxiaohua@fosunpharma.com